Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Huali Wu, Jeffrey R Infante, Vicki L Keedy, Suzanne F Jones, Emily Chan, Johanna C Bendell, Wooin Lee, Whitney P Kirschbrown, Beth A Zamboni, Satoshi Ikeda, Hiroshi Kodaira, Mace L Rothenberg, Howard A Burris$suffix/text()$suffix/text() & William C Zamboni. (2015) Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors. International Journal of Nanomedicine 10, pages 1201-1209.
Read now
Read now
Huali Wu, Ramesh K Ramanathan, Beth A Zamboni, Sandra Strychor, Suresh Ramalingam, Robert P Edwards, David M Friedland, Ronald G Stoller, Chandra P Belani, Lauren J Maruca, Yung-Jue Bang & William C Zamboni. (2012) Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients. International Journal of Nanomedicine 7, pages 5555-5564.
Read now
Read now
Gina Song, Huali Wu, Keisuke Yoshino & William C. Zamboni. (2012) Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs. Journal of Liposome Research 22:3, pages 177-192.
Read now
Read now
Articles from other publishers (35)
Miriam Giambelluca, Elena Markova, Claire Louet, Bjørg Steinkjer, Rune Sundset, Nataša Škalko-Basnet & Sjoerd Hak. (2023) Liposomes - Human phagocytes interplay in whole blood: effect of liposome design. Nanomedicine: Nanotechnology, Biology and Medicine 54, pages 102712.
Crossref
Crossref
Yue Li, Laren Lofchy, Guankui Wang, Hanmant Gaikwad, Mayumi Fujita & Dmitri Simberg. (2022)
PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities
via
Passive Extravasation across “Leaky” Endothelium
. ACS Nano 16:4, pages 6349-6358.
Crossref
Crossref
M. S. Sudheesh, K. Pavithran & Sabitha M. (2022) Revisiting the outstanding questions in cancer nanomedicine with a future outlook. Nanoscale Advances 4:3, pages 634-653.
Crossref
Crossref
Md Abdus Subhan, Satya Siva Kishan Yalamarty, Nina Filipczak, Farzana Parveen & Vladimir P. Torchilin. (2021) Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. Journal of Personalized Medicine 11:6, pages 571.
Crossref
Crossref
Iara Maíra de Oliveira Viana, Sabrina Roussel, Joan Defrêne, Eliana Martins Lima, Frédéric Barabé & Nicolas Bertrand. (2021) Innate and adaptive immune responses toward nanomedicines. Acta Pharmaceutica Sinica B 11:4, pages 852-870.
Crossref
Crossref
Wen Jiang, Yifan Wang, Jennifer A. Wargo, Frederick F. Lang & Betty Y. S. Kim. (2020) Considerations for designing preclinical cancer immune nanomedicine studies. Nature Nanotechnology 16:1, pages 6-15.
Crossref
Crossref
Farshad Moradi Kashkooli, M. Soltani & Mohammad Souri. (2020) Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies. Journal of Controlled Release 327, pages 316-349.
Crossref
Crossref
William C. Zamboni, Janos Szebeni, Serguei V. Kozlov, Andrew T. Lucas, Joseph A. Piscitelli & Marina A. Dobrovolskaia. (2018) Animal models for analysis of immunological responses to nanomaterials: Challenges and considerations. Advanced Drug Delivery Reviews 136-137, pages 82-96.
Crossref
Crossref
Jamie L. Betker, Dallas Jones, Christine R. Childs, Karen M. Helm, Kristina Terrell, Maria A. Nagel & Thomas J. Anchordoquy. (2018) Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery. Journal of Controlled Release 286, pages 85-93.
Crossref
Crossref
Anne Rodallec, Sebastien Benzekry, Bruno Lacarelle, Joseph Ciccolini & Raphaelle Fanciullino. (2018) Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology. Critical Reviews in Oncology/Hematology 129, pages 1-12.
Crossref
Crossref
Andrew T Lucas, Lauren SL Price, Allison Schorzman & William C Zamboni. (2017) Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents. Nanomedicine 12:16, pages 2021-2042.
Crossref
Crossref
Andrew T. Lucas, Leah B. Herity, Zack A. Kornblum, Andrew J. Madden, Alberto Gabizon, Alexander V. Kabanov, Rose T. Ajamie, David M. Bender, Palaniappan Kulanthaivel, Manuel V. Sanchez-Felix, Henry A. Havel & William C. Zamboni. (2017) Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs. International Journal of Pharmaceutics 526:1-2, pages 443-454.
Crossref
Crossref
Fangfang Chen, Guankui Wang, James I. Griffin, Barbara Brenneman, Nirmal K. Banda, V. Michael Holers, Donald S. Backos, LinPing Wu, Seyed Moein Moghimi & Dmitri Simberg. (2016) Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nature Nanotechnology 12:4, pages 387-393.
Crossref
Crossref
Andrew T. Lucas, Taylor F. White, Allison M. Deal, Leah B. Herity, Gina Song, Charlene M. Santos & William C. Zamboni. (2017) Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models. Nanomedicine: Nanotechnology, Biology and Medicine 13:2, pages 471-482.
Crossref
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeRachel Tyson, Leah Osae, Andrew J. Madden, Andrew T. Lucas & William C. Zamboni. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production
469
496
.
Min Li, Peng Zou, Katherine Tyner & Sau Lee. (2016) Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles. The AAPS Journal 19:1, pages 26-42.
Crossref
Crossref
Andrew T. Lucas, Andrew J. Madden & William C. Zamboni. (2016) Challenges in preclinical to clinical translation for anticancer carrier‐mediated agents. WIREs Nanomedicine and Nanobiotechnology 8:5, pages 642-653.
Crossref
Crossref
Hugh Giovinazzo, Parag Kumar, Arif Sheikh, Kristina M. Brooks, Marija Ivanovic, Mark Walsh, Whitney P. Caron, Richard J. Kowalsky, Gina Song, Ann Whitlow, Daniel L. Clarke-Pearson, Wendy R. Brewster, Linda Van Le, Beth A. Zamboni, Victoria Bae-Jump, Paola A. Gehrig & William C. Zamboni. (2016) Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemotherapy and Pharmacology 77:3, pages 565-573.
Crossref
Crossref
Anna N. Ilinskaya & Marina A. Dobrovolskaia. 2016. Polymer Nanoparticles for Nanomedicines. Polymer Nanoparticles for Nanomedicines
505
520
.
Swetha Inturi, Guankui Wang, Fangfang Chen, Nirmal K. Banda, V. Michael Holers, LinPing Wu, Seyed Moein Moghimi & Dmitri Simberg. (2015) Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. ACS Nano 9:11, pages 10758-10768.
Crossref
Crossref
Zahra Ajgal, Nicolas Chapuis, George Emile, Anatole Cessot, Jean Marie Tigaud, Olivier Huillard, Pascaline Boudou-Rouquette, Michaela Fontenay, Francois Goldwasser & Jerome Alexandre. (2015) Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time: assessment of monocyte count and baseline clinical parameters. Cancer Chemotherapy and Pharmacology 76:5, pages 1033-1039.
Crossref
Crossref
Gina Song, Teresa K. Tarrant, Taylor F. White, David A. Barrow, Charlene M. Santos, Roman G. Timoshchenko, Suzan K. Hanna, Ramesh K. Ramanathan, Craig R. Lee, Victoria L. Bae-Jump, Paola A. Gehrig & William C. Zamboni. (2015) Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancer. Nanomedicine: Nanotechnology, Biology and Medicine 11:7, pages 1797-1807.
Crossref
Crossref
Jennifer S Petschauer, Andrew J Madden, Whitney P Kirschbrown, Gina Song & William C Zamboni. (2015) The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents. Nanomedicine 10:3, pages 447-463.
Crossref
Crossref
Jeremy A. Bartlett, Marcus Brewster, Paul Brown, Donna Cabral-Lilly, Celia N. Cruz, Raymond David, W. Mark Eickhoff, Sabine Haubenreisser, Abigail Jacobs, Frank Malinoski, Elaine Morefield, Ritu Nalubola, Robert K. Prud’homme, Nakissa Sadrieh, Christie M. Sayes, Hripsime Shahbazian, Nanda Subbarao, Lawrence Tamarkin, Katherine Tyner, Rajendra Uppoor, Margaret Whittaker-Caulk & William Zamboni. (2014) Summary Report of PQRI Workshop on Nanomaterial in Drug Products: Current Experience and Management of Potential Risks. The AAPS Journal 17:1, pages 44-64.
Crossref
Crossref
Vishakha V. Ambardekar & Stephan T. Stern. 2015. Non-Biological Complex Drugs. Non-Biological Complex Drugs
261
287
.
Gina Song, David B. Darr, Charlene M. Santos, Mark Ross, Alain Valdivia, Jamie L. Jordan, Bentley R. Midkiff, Stephanie Cohen, Nana Nikolaishvili-Feinberg, C. Ryan Miller, Teresa K. Tarrant, Arlin B. Rogers, Andrew C. Dudley, Charles M. Perou & William C. Zamboni. (2014) Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models. Clinical Cancer Research 20:23, pages 6083-6095.
Crossref
Crossref
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly & Omid C. Farokhzad. (2014) Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews 66, pages 2-25.
Crossref
Crossref
Whitney P. Caron, John C. Lay, Alan M. Fong, Ninh M. La-Beck, Parag Kumar, Suzanne E. Newman, Haibo Zhou, Jane H. Monaco, Daniel L. Clarke-Pearson, Wendy R. Brewster, Linda Van Le, Victoria L. Bae-Jump, Paola A. Gehrig & William C. Zamboni. (2013) Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology. Journal of Pharmacology and Experimental Therapeutics 347:3, pages 599-606.
Crossref
Crossref
Huali Wu, Jeffrey R. Infante, Vicki L. Keedy, Suzanne F. Jones, Emily Chan, Johanna C. Bendell, Wooin Lee, Beth A. Zamboni, Satoshi Ikeda, Hiroshi Kodaira, Mace L. Rothenberg, Howard A. BurrisIIIIII & William C. Zamboni. (2013) Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors. European Journal of Clinical Pharmacology 69:12, pages 2073-2081.
Crossref
Crossref
Whitney P. Caron, Katherine P. Morgan, Beth A. Zamboni & William C. Zamboni. (2013) A Review of Study Designs and Outcomes of Phase I Clinical Studies of Nanoparticle Agents Compared with Small-Molecule Anticancer Agents. Clinical Cancer Research 19:12, pages 3309-3315.
Crossref
Crossref
Carey K. Anders, Barbara Adamo, Olga Karginova, Allison M. Deal, Sumit Rawal, David Darr, Allison Schorzman, Charlene Santos, Ryan Bash, Tal Kafri, Lisa Carey, C. Ryan Miller, Charles M. Perou, Norman Sharpless & William C. Zamboni. (2013) Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer. PLoS ONE 8:5, pages e61359.
Crossref
Crossref
William C. Zamboni, Vladimir Torchilin, Anil K. Patri, Jeff Hrkach, Stephen Stern, Robert Lee, Andre Nel, Nicholas J. Panaro & Piotr Grodzinski. (2012) Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance. Clinical Cancer Research 18:12, pages 3229-3241.
Crossref
Crossref
W P Caron, G Song, P Kumar, S Rawal & W C Zamboni. (2012) Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents. Clinical Pharmacology & Therapeutics 91:5, pages 802-812.
Crossref
Crossref
Mark J. Ernsting, Warren D. Foltz, Elijus Undzys, Tatsuaki Tagami & Shyh-Dar Li. (2012) Tumor-targeted drug delivery using MR-contrasted docetaxel – Carboxymethylcellulose nanoparticles. Biomaterials 33:15, pages 3931-3941.
Crossref
Crossref
Whitney P. Caron, Harvey Clewell, Robert Dedrick, Ramesh K. Ramanathan, Whitney L. Davis, Ning Yu, Margaret Tonda, Jan H. Schellens, Jos H. Beijnen & William C. Zamboni. (2011) Allometric scaling of pegylated liposomal anticancer drugs. Journal of Pharmacokinetics and Pharmacodynamics 38:5, pages 653-669.
Crossref
Crossref